TherapeuticsMD Inc reports results for the quarter ended in June - Earnings Summary

TherapeuticsMD

04/08/2021 13:57

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss of 11 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 11 cents per share.
* Revenue rose 114.9% to $23.00 million from a year ago; 
analysts expected $21.36 million. 
* TherapeuticsMD Inc's reported EPS for the quarter was a loss
of 11 cents​.
* The mean earnings estimate of analysts had fallen by about 10%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* TherapeuticsMD Inc shares had fallen by 17.6% this quarter and
lost 19.0% so far this year.
* The company reported a quarterly loss of $42.65 million.
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 4 at 12:57 p.m.  ​All
figures in US dollars unless otherwise stated